This company is no longer active
0JDB Stock Overview
A medical genetics company, that provides genetic information to improve healthcare of people in the United States, Canada, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Invitae Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.0005 |
| 52 Week High | US$1.25 |
| 52 Week Low | US$0.0001 |
| Beta | 2.8 |
| 11 Month Change | 0% |
| 3 Month Change | -50.00% |
| 1 Year Change | -99.96% |
| 33 Year Change | -100.00% |
| 5 Year Change | -100.00% |
| Change since IPO | -99.99% |
Recent News & Updates
Recent updates
Shareholder Returns
| 0JDB | GB Healthcare | GB Market | |
|---|---|---|---|
| 7D | 0% | 0.4% | 2.2% |
| 1Y | -100.0% | -22.5% | 8.8% |
Return vs Industry: 0JDB underperformed the UK Healthcare industry which returned -24.7% over the past year.
Return vs Market: 0JDB underperformed the UK Market which returned 6.6% over the past year.
Price Volatility
| 0JDB volatility | |
|---|---|
| 0JDB Average Weekly Movement | n/a |
| Healthcare Industry Average Movement | 6.2% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in GB Market | 10.2% |
| 10% least volatile stocks in GB Market | 2.6% |
Stable Share Price: 0JDB's share price has been volatile over the past 3 months.
Volatility Over Time: Insufficient data to determine 0JDB's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2010 | 1,700 | Ken Knight | www.invitae.com |
Invitae Corporation, a medical genetics company, that provides genetic information to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, precision oncology, women's health, rare diseases, and pharmacogenomics; digital health solutions; and health data services. It serves patients, healthcare providers, biopharma companies, and other partners.
Invitae Corporation Fundamentals Summary
| 0JDB fundamental statistics | |
|---|---|
| Market cap | US$114.60k |
| Earnings (TTM) | -US$1.44b |
| Revenue (TTM) | US$481.58m |
0.0x
P/S Ratio0.0x
P/E RatioIs 0JDB overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 0JDB income statement (TTM) | |
|---|---|
| Revenue | US$481.58m |
| Cost of Revenue | US$350.95m |
| Gross Profit | US$130.64m |
| Other Expenses | US$1.57b |
| Earnings | -US$1.44b |
Last Reported Earnings
Sep 30, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -5.03 |
| Gross Margin | 27.13% |
| Net Profit Margin | -299.14% |
| Debt/Equity Ratio | -124.7% |
How did 0JDB perform over the long term?
See historical performance and comparison